Domenico wrote that drug pricing is remarkable for its "puzzling opacity," but added that it is "not necessary to unravel the ...

Patients who rely on co-pay assistance from drugmakers are typically heavy users of health care for whom delays in treatment ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company fully dedicated to developing therapeutics ...

SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnology company focused on treating inflammation through resolution therapy, today provides an update following it ...

Biogen BIIB and Amgen AMGN are two of the biggest biotech companies in the world. Amgen has a strong presence in the oncology ...

A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Ranked by Gross volume of Silicon Valley sales closed in 2025 Showcase your company news with guaranteed exposure both in print and online Downtown Minneapolis and St. Paul are transforming as work ...

From hosting an intimate concert by Sting to securing a comedian such as Jerry Seinfeld… This program recognizes 40 individuals under the age of 40 who have made an impact… Celebrate Growth and ...

Those conversations become even more common when budgets tighten or performance fluctuates. The challenge is that many advertisers still rely on outdated benchmark reports or broad industry ...

Through the Kilts Center’s relationship with Nielsen, the center provides academic researchers at the University of Chicago Booth School of Business and around the world access to Nielsen’s US Ad ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...